Safety and technical feasibility of percutaneous ablation for lymph node metastases of hepatocellular carcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi: 10.3322/caac.21262.
   PubMed Web of Science ®Google Scholar
• Ercolani G, Grazi GL, Ravaioli M, et al. The role of lymphadenectomy for liver tumors: further considerations on the appropriateness of treatment strategy. Ann Surg. 2004;239:202–209. doi: 10.1097/01.sla.0000109154.00020.e0.
   PubMed Web of Science ®Google Scholar
• Hasegawa K, Makuuchi M, Kokudo N, et al. Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese Nationwide Survey. Ann Surg. 2014;259:166–170. doi: 10.1097/SLA.0b013e31828d4960.
   PubMed Web of Science ®Google Scholar
• Watanabe J, Nakashima O, Kojiro M. Clinicopathologic study on lymph node metastasis of hepatocellular carcinoma: a retrospective study of 660 consecutive autopsy cases. Jpn J Clin Oncol. 1994;24(1):37–41.
   PubMed Web of Science ®Google Scholar
• Xia F, Wu L, Lau WY, et al. Positive lymph node metastasis has a marked impact on the long-term survival of patients with hepatocellular carcinoma with extrahepatic metastasis. PLoS One. 2014;9:e95889. doi: 10.1371/journal.pone.0095889.
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8:378–382. doi: 10.1038/nrclinonc.2011.44.
   PubMed Web of Science ®Google Scholar
• Yamashita H, Nakagawa K, Shiraishi K, et al. Radiotherapy for lymph node metastases in patients with hepatocellular carcinoma: retrospective study. J Gastroenterol Hepatol. 2007;22:523–527. doi: 10.1111/j.1440-1746.2006.04450.x.
   PubMed Web of Science ®Google Scholar
• Kang TW, Rhim H. Recent advances in tumor ablation for hepatocellular carcinoma. Liver Cancer. 2015;4:176–187. doi: 10.1159/000367740.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM. Recent advances in the image-guided tumor ablation of liver malignancies: radiofrequency ablation with multiple electrodes, real-time multimodality fusion imaging, and new energy sources. Korean J Radiol. 2018;19:545–559. doi: 10.3348/kjr.2018.19.4.545.
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhai B. A recent advance in image-guided locoregional therapy for hepatocellular carcinoma. Gastrointest Tumors. 2016;3:90–102. doi: 10.1159/000445888.
   PubMed Web of Science ®Google Scholar
• Chinnaratha MA, Chuang MY, Fraser RJ, et al. Percutaneous thermal ablation for primary hepatocellular carcinoma: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:294–301. doi: 10.1111/jgh.13028.
   PubMed Web of Science ®Google Scholar
• Li W, Man W, Guo H, et al. Clinical study of transcatheter arterial chemoembolization combined with microwave ablation in the treatment of advanced hepatocellular carcinoma. J Can Res Ther. 2016;12:C217–C220. doi: 10.4103/0973-1482.200598.
   PubMed Web of Science ®Google Scholar
• Nouso K, Kariyama K, Nakamura S, et al. Application of radiofrequency ablation for the treatment of intermediate-stage hepatocellular carcinoma. J Gastroenterol Hepatol. 2017;32:695–700. doi: 10.1111/jgh.13586.
   PubMed Web of Science ®Google Scholar
• Cabrera R, Nelson DR. Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther. 2010;31:461–476. doi: 10.1111/j.1365-2036.2009.04200.x.
   PubMed Web of Science ®Google Scholar
• Pompili M, Nicolardi E, Abbate V, et al. Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol. 2011;17:3126–3132. doi: 10.3748/wjg.v17.i26.3126.
   PubMed Web of Science ®Google Scholar
• Sethi A, Ellrichmann M, Dhar S, et al. Endoscopic ultrasound-guided lymph node ablation with a novel radiofrequency ablation probe: feasibility study in an acute porcine model. Endoscopy. 2014;46:411–415. doi: 10.1055/s-0034-1364933.
   PubMed Web of Science ®Google Scholar
• Pan T, Xie QK, Lv N, et al. Percutaneous CT-guided radiofrequency ablation for lymph node oligometastases from hepatocellular carcinoma: a propensity score-matching analysis. Radiology. 2017;282:259–270. doi: 10.1148/radiol.2016151807.
   PubMed Web of Science ®Google Scholar
• Gao F, Gu Y, Huang J, et al. Radiofrequency ablation of retroperitoneal metastatic lymph nodes from hepatocellular carcinoma. Acad Radiol. 2012;19:1035–1040. doi: 10.1016/j.acra.2012.04.003.
   PubMed Web of Science ®Google Scholar
• Shao H, Arellano RS. Percutaneous microwave ablation of hepatocellular carcinoma metastatic to a mesocolic lymph node. J Vasc Interv Radiol. 2017;28:1281–1283. doi: 10.1016/j.jvir.2017.06.001.
   PubMed Web of Science ®Google Scholar
• Liu SR, Xiao YY, Le Pivert PJ, et al. CT-guided percutaneous chemoablation using an ethanol-ethiodol-doxorubicin emulsion for the treatment of metastatic lymph node carcinoma: a comparative study. Technol Cancer Res Treat. 2013;12:165–172. doi: 10.7785/tcrt.2012.500254.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273:241–260. doi: 10.1148/radiol.14132958. PubMed PMID: 24927329; PubMed Central PMCID: PMCPMC4263618.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:52–60. doi: 10.1055/s-0030-1247132.
   PubMed Web of Science ®Google Scholar
• Omary RA, Bettmann MA, Cardella JF, et al. Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol. 2003;14:S293–S295.
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Daglilar ES, Kamionek M, et al. Evaluation of radiofrequency ablation using a 1-Fr wire electrode in porcine pancreas, liver, gallbladder, spleen, kidney, stomach, and lymph nodes: a pilot study. Digestive Endoscopy. 2016;28:465–468.
   Web of Science ®Google Scholar
• Awazu M, Fukumoto T, Takebe A, et al. Lymphadenectomy combined with locoregional treatment for multiple advanced hepatocellular carcinoma with lymph node metastases. Kobe J Med Sci. 2013;59:E17–E27.
   PubMedGoogle Scholar
• Zeng ZC, Tang ZY, Fan J, et al. Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients. Int J Radiat Oncol Biol Phys. 2005;63:1067–1076. doi: 10.1016/j.ijrobp.2005.03.058.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000;214:761–768. doi: 10.1148/radiology.214.3.r00mr02761.
   PubMed Web of Science ®Google Scholar
• Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242:158–171.
   PubMed Web of Science ®Google Scholar
• Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592–599.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236. doi: 10.1016/j.jhep.2018.03.019.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Di Maso M, Muscatiello N. Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2016;32:339–344. doi: 10.3109/02656736.2015.1127434.
   PubMed Web of Science ®Google Scholar
• Shiina S, Sato K, Tateishi R, et al. Percutaneous ablation for hepatocellular carcinoma: comparison of various ablation techniques and surgery. Can J Gastroenterol Hepatol. 2018;2018:1. doi: 10.1155/2018/4756147.
   Web of Science ®Google Scholar
• Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34:863–869. doi: 10.1080/02656736.2017.1370728.
   PubMed Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Guiu B, et al. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial. Lancet Gastroenterol Hepatol. 2018;3:317–325. doi: 10.1016/S2468-1253(18)30029-3.
   PubMed Web of Science ®Google Scholar
• Teratani T, Yoshida H, Shiina S, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006;43:1101–1108. doi: 10.1002/hep.21164.
   PubMed Web of Science ®Google Scholar
• Wang L, Ge M, Xu D, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma. J Can Res Ther. 2014;10:144–149. doi: 10.4103/0973-1482.145844.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Guan Z, Chen Z, et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial. Eur J Cancer. 2012;48:1452–1465. doi: 10.1016/j.ejca.2011.12.006.
   PubMed Web of Science ®Google Scholar
• Keyver-Paik MD, Arden JM, Luders C, et al. Impact of chemotherapy on retroperitoneal lymph nodes in ovarian cancer. Anticancer Res. 2016;36:1815–1824.
   PubMed Web of Science ®Google Scholar
• Ishihara S, Kawai K, Tanaka T, et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum. 2017;60:469–476. doi: 10.1097/DCR.0000000000000752.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Mine S, Yamada K, et al. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus. Gen Thorac Cardiovasc Surg. 2014;62:685–692. doi: 10.1007/s11748-014-0444-4.
   PubMedGoogle Scholar
• Kim K, Chie EK, Kim W, et al. Absence of symptom and intact liver function are positive prognosticators for patients undergoing radiotherapy for lymph node metastasis from hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2010;78:729–734. 1 doi: 10.1016/j.ijrobp.2009.08.047.
   PubMed Web of Science ®Google Scholar
• Yoon WJ, Daglilar ES, Kamionek M, et al. Evaluation of radiofrequency ablation using the 1-Fr wire electrode in the porcine pancreas, liver, gallbladder, spleen, kidney, stomach, and lymph nodes: a pilot study. Dig Endosc. 2016;28:465–468. 1doi: 10.1111/den.12575.
   Web of Science ®Google Scholar